Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome.

Abstract

The failure of reproductive success in polycystic ovary syndrome (PCOS) patients could be in part due to endometrial dysfunction. However, no studies have investigated any causality between androgen, androgen receptor (AR) expression, and adenosine monophosphate activated protein kinase (AMPK) activation in the endometrium under physiological and pathological conditions. In the present study, we show that 1) endometrial AR expression levels fluctuate in non-PCOS and PCOS patients during the menstrual cycle; 2) the menstrual phase-dependent alteration of p-AMPKα expression occurs in non-PCOS patients but not in PCOS patients; 3) AR expression is higher in PCOS patients than non-PCOS patients during hyperplasia while AMPKα activation (indicated by the ratio of p-AMPKα to AMPKα); and 4) co-localization of AR and Ki-67 in epithelial cell nuclei is observed in endometrial hyperplasia. Importantly, using in vitro human tissue culture and an in vivo 5α-dihydrotestosterone-treated rat model, we show that the action of androgen on AMPKα activation is likely mediated through nuclear AR, especially in epithelial cells. Collectively, we present evidence that AR expression and AMPKα activation depend on menstrual cycle phase and the presence of PCOS, and the data suggest that AR-mediated regulation of AMPKα activation might play a role in the development of endometrial hyperplasia.

• Authors: Xin Li, Bano Pishdari, Peng Cui, Min Hu, Hong-Ping Yang, Yan-Rong Guo, Hong-Yuan Jiang, Yi Feng, Håkan Billig, Ruijin Shao
• Journal: International journal of biological sciences (Int J Biol Sci) Vol. 11 Issue 12 Pg. 1376-89 ( 2015) ISSN: 1449-2288 [Electronic] Australia
• PMID: 26681917 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• CDKN1A protein, human
• Cyclin-Dependent Kinase Inhibitor p21
• Ki-67 Antigen
• Receptors, Androgen
• Dihydrotestosterone
• Flutamide
• Adenylate Kinase

Topics

• Adenylate Kinase (metabolism)
• Animals
• Cyclin-Dependent Kinase Inhibitor p21 (metabolism)
• Dihydrotestosterone (pharmacology)
• Endometrium (enzymology, metabolism)
• Female
• Flutamide (pharmacology)
• Humans
• In Vitro Techniques
• Ki-67 Antigen (metabolism)
• Phosphorylation
• Polycystic Ovary Syndrome (enzymology, metabolism)
• Rats
• Rats, Wistar
• Receptors, Androgen (metabolism)